Ordinary Adjustment | Morgan Stanley U.S. Small Cap Biotechnology Index | Effective Date 2nd June 2025
Morgan Stanley U.S. Small Cap Biotechnology Index:
In the ordinary adjustment, the following composition will be implemented effective open 2nd June 2025:
| 89BIO INC |
| ACADIA PHARMACEUTICALS INC |
| ADMA BIOLOGICS INC |
| AGIOS PHARMACEUTICALS INC |
| AKERO THERAPEUTICS INC |
| ALKERMES PLC |
| AMICUS THERAPEUTICS INC |
| AMNEAL PHARMACEUTICALS INC |
| ANI PHARMACEUTICALS INC |
| APOGEE THERAPEUTICS ORD |
| ARCELLX INC |
| ARCUTIS BIOTHERAPEUTICS INC |
| ARROWHEAD PHARMACEUTICALS INC |
| AVIDITY BIOSCIENCES INC |
| AXSOME THERAPEUTICS INC |
| BEAM THERAPEUTICS INC |
| BIOCRYST PHARMACEUTICALS INC |
| BRIDGEBIO PHARMA INC |
| CATALYST PHARMACEUTICALS INC |
| CG ONCOLOGY INC |
| CRINETICS PHARMACEUTICALS INC |
| CYTOKINETICS INC |
| DENALI THERAPEUTICS INC |
| DYNAVAX TECHNOLOGIES CORP |
| DYNE THERAPEUTICS INC |
| EDGEWISE THERAPEUTICS INC |
| HARMONY BIOSCIENCES HOLDINGS INC |
| IDEAYA BIOSCIENCES INC |
| JANUX THERAPEUTICS INC |
| KRYSTAL BIOTECH INC |
| KYMERA THERAPEUTICS INC |
| MIRUM PHARMACEUTICALS INC |
| MOONLAKE IMMUNOTHERAPEUTICS |
| NEW BIOHAVEN |
| NOVAVAX INC |
| Nuvalent Inc |
| ORGANON & CO |
| PACIRA BIOSCIENCES INC |
| PERRIGO CO PLC |
| PRESTIGE CONSUMER HEALTHCARE INC |
| PROTAGONIST THERAPEUTICS INC |
| PTC THERAPEUTICS INC |
| RHYTHM PHARMACEUTICALS INC |
| SAREPTA THERAPEUTICS INC |
| SCHOLAR ROCK HOLDING CORP |
| SOLENO THERAPEUTICS INC |
| SUMMIT THERAPEUTICS PLC |
| TARSUS PHARMACEUTICALS INC |
| TRAVERE THERAPEUTICS INC |
| ULTRAGENYX PHARMACEUTICAL INC |
| VAXCYTE INC |
| VIKING THERAPEUTICS INC |